You are here: Home » Reuters » News
Business Standard

Denmark's Novo Nordisk offers $3.1 billion for Belgian biotech group Ablynx

Reuters  |  BRUSSELS 

BRUSSELS (Reuters) - Danish drugmaker Novo Nordisk said on Monday it had made a 2.6 billion euros ($3.12 billion) bid for Belgian biotech group Ablynx, the latest offer by a big pharmaceutical company for a Belgian biotech firm.Ablynx already rejected an offer by the Danish group on Dec. 14 and Novo Nordisk said the new bid, made on Dec. 22, was some 14 percent higher. The Belgian company was not immediately available for comment on Monday."Novo Nordisk regrets that the board of directors of Ablynx has so far declined to engage in any discussions, despite the proposals which have been put ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Mon, January 08 2018. 13:01 IST
RECOMMENDED FOR YOU